Versant Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
26
- Investments
-
504
- Portfolio
-
41
- Exits
-
240
Versant Ventures General Information
Company Description
Founded in 1999, Versant Ventures is a venture capital investment firm based in San Francisco, California. The firm seeks to invest in the healthcare sector. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.versantventures.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- One Sansome Street
- Suite 1650
- San Francisco, CA 94104
- United States
Versant Ventures Investments (504)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Nouscom | 19-Oct-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Nexo Therapeutics | 27-Mar-2026 | Drug Discovery | Clinical Trials - General | |||
| Dayra Therapeutics | 24-Nov-2025 | Drug Delivery | Startup | |||
| Gate Bioscience | 06-Nov-2025 | Drug Discovery | Generating Revenue | |||
| AllRock Bio | 17-Sep-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Dualitas Therapeutics | 16-Sep-2025 | Drug Discovery | Startup | |||
| iECURE | 16-Jul-2025 | Other Pharmaceuticals and Biotechnology | Clinical Trials - Phase 2 | |||
| Sapient Intelligence | 08-May-2025 | Business/Productivity Software | Generating Revenue | |||
| Jade Biosciences | 28-Apr-2025 | PIPE | Biotechnology | Generating Revenue/Not Profitable | ||
| Helicore Biopharma | 16-Jan-2025 | Early Stage VC | Drug Discovery | Pre-Clinical Trials |
Versant Ventures Exits (240)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Lycia Therapeutics | 23-Oct-2026 | IPO | |
| Abdera Therapeutics | 07-Aug-2026 | ||
| FireFly Bio | 29-Jul-2026 | ||
| Jade Biosciences | 03-Jun-2026 | ||
| Enceladus Bio | 27-Apr-2026 | ||
| MD Start | 01-Feb-2026 | ||
| Anokion | 06-Dec-2025 | ||
| SixPeaks Bio | 22-Oct-2025 | ||
| Vector Biopharma | 07-Jul-2025 | Bankruptcy: Liquidation | |
| Neli Therapeutics | 01-Jul-2025 | Merger/Acquisition |
Versant Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Versant Ventures Investments by Industry, Year, and Region
Versant Ventures Co-Investors (104)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 6 |
|
|
||
| Andreessen Horowitz |
|
|
|||
| GV |
|
|
|||
| New Enterprise Associates |
|
|
|||
| RA Capital Management |
|
|
Versant Ventures Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Ridgeline Discovery | Basel, Switzerland | 2017 | |
| Highline Therapeutics | New York, NY | 2015 |
Versant Ventures FAQs
-
What is Versant Ventures?
Founded in 1999, Versant Ventures is a venture capital investment firm based in San Francisco, California.
-
When was Versant Ventures founded?
Versant Ventures was founded in 1999.
-
Where is Versant Ventures headquartered?
Versant Ventures is headquartered in San Francisco, CA.
-
What is Versant Ventures's total asset value?
Versant Ventures has around in total assets under management.
-
How many investments has Versant Ventures made?
Versant Ventures has made 504 investments.
-
What has Versant Ventures invested in?
Versant Ventures has made numerous investments in companies like Nouscom, Nexo Therapeutics, and Dayra Therapeutics within the Drug Discovery and Drug Delivery industries.
-
What has Versant Ventures invested in recently?
Versant Ventures's latest investment was on 19-Oct-2026 in Nouscom, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process